Partially Neutralizing Potency against Emerging Genotype I Virus among Children Received Formalin-Inactivated Japanese Encephalitis Virus Vaccine

PLoS Neglected Tropical Diseases

Volumn 6, Issue 9, 2012, Pages

  Fan, Yi Chin ^a   Chen, Jo Mei ^a   Chiu, Hsien Chung ^b   Chen, Yi Ying ^a   Lin, Jen Wei ^a   Shih, Chen Chang ^c   Chen, Chih Ming ^a,d   Chang, Chao Chin ^a   Chang, Gwong Jen J ^e   Chiou, Shyan Song ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c MENNONITE CHRISTIAN HOSPITAL   (Taiwan)

^d TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY;

ADOLESCENT; AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CHILD; CONTROLLED STUDY; FLOW CYTOMETRY; GENOTYPE; HUMAN; HUMAN CELL; INFANT; INFECTION RATE; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; JAPANESE ENCEPHALITIS VIRUS GENOTYPE I; JAPANESE ENCEPHALITIS VIRUS GENOTYPE III; NEWBORN; NONHUMAN; PRESCHOOL CHILD; SCHOOL CHILD; SEROLOGY; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ADOLESCENT; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ASIA; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; GENOTYPE; HUMANS; INFANT; JAPANESE ENCEPHALITIS VACCINES; MICE; NEUTRALIZATION TESTS; TAIWAN; VACCINES, INACTIVATED; VIRAL PLAQUE ASSAY;

EID: 84866944272     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001834     Document Type: Article

References (45)

1. van den Hurk AF, Ritchie SA, Mackenzie JS, (2009) Ecology and geographical expansion of Japanese encephalitis virus. Annu Rev Entomol 54: 17-35.
2. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 42: 1-15.
3. Misra UK, Kalita J, (2010) Overview: Japanese encephalitis. Prog Neurobiol 91: 108-120.
4. Halstead SB, Thomas SJ, (2011) New Japanese encephalitis vaccines: alternatives to production in mouse brain. Expert Rev Vaccines 10: 355-364.
5. Halstead SB, Thomas SJ, (2010) New vaccines for Japanese encephalitis. Curr Infect Dis Rep 12: 174-180.
6. Unni SK, Ruzek D, Chhatbar C, Mishra R, Johri MK, et al. (2011) Japanese encephalitis virus: from genome to infectome. Microbes Infect 13: 312-321.
7. Wu YC, Huang YS, Chien LJ, Lin TL, Yueh YY, et al. (1999) The epidemiology of Japanese encephalitis on Taiwan during 1966-1997. Am J Trop Med Hyg 61: 78-84.
8. Yang SE, Pan MJ, Tseng HF, Liau MY, (2006) The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine-results from 30 years experience in Taiwan. Vaccine 24: 2669-2673.
9. Solomon T, Ni H, Beasley DW, Ekkelenkamp M, Cardosa MJ, et al. (2003) Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol 77: 3091-3098.
10. Pan XL, Liu H, Wang HY, Fu SH, Liu HZ, et al. (2011) Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol 85: 9847-9853.
11. Ma SP, Yoshida Y, Makino Y, Tadano M, Ono T, et al. (2003) Short report: a major genotype of Japanese encephalitis virus currently circulating in Japan. Am J Trop Med Hyg 69: 151-154.
12. Nga PT, del Carmen Parquet M, Cuong VD, Ma SP, Hasebe F, et al. (2004) Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia. J Gen Virol 85: 1625-1631.
13. Nitatpattana N, Dubot-Peres A, Gouilh MA, Souris M, Barbazan P, et al. (2008) Change in Japanese encephalitis virus distribution, Thailand. Emerg Infect Dis 14: 1762-1765.
14. Yun SM, Cho JE, Ju YR, Kim SY, Ryou J, et al. (2010) Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005. Virol J 7: 127.
15. Huang JH, Lin TH, Teng HJ, Su CL, Tsai KH, et al. (2010) Molecular epidemiology of Japanese encephalitis virus, Taiwan. Emerg Infect Dis 16: 876-878.
16. Chen YY, Fan YC, Tu WC, Chang RY, Shih CC, et al. (2011) Japanese encephalitis virus genotype replacement, Taiwan, 2009-2010. Emerg Infect Dis 17: 2354-2356.
17. Chiou SS, Tsai KH, Huang CG, Liao YK, Chen WJ, (2007) High antibody prevalence in an unconventional ecosystem is related to circulation of a low-virulent strain of Japanese encephalitis virus. Vaccine 25: 1437-1443.
18. Shyu WR, Wang YC, Chin C, Chen WJ, (1997) Assessment of neutralizing antibodies elicited by a vaccine (Nakayama) strain of Japanese encephalitis virus in Taiwan. Epidemiol Infect 119: 79-83.
19. Beasley DW, Li L, Suderman MT, Guirakhoo F, Trent DW, et al. (2004) Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine 22: 3722-3726.
20. Liu X, Yu Y, Li M, Liang G, Wang H, et al. (2011) Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China. Vaccine 29: 2127-2130.
21. Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, et al. (2011) Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO((R))) induced neutralizing antibody titers. Vaccine 29: 5925-5931.
22. Chiou SS, Chen WJ, (2007) Phenotypic changes in the Japanese encephalitis virus after one passage in Neuro-2a cells: generation of attenuated strains of the virus. Vaccine 26: 15-23.
23. Luca VC, Abimansour J, Nelson CA, Fremont DH, (2012) Crystal structure of the Japanese encephalitis virus envelope protein. J Virol 86: 2337-2346.
24. Crill WD, Chang GJ, (2004) Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol 78: 13975-13986.
25. Konishi E, Tabuchi Y, Yamanaka A, (2010) A simple assay system for infection-enhancing and-neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells. J Virol Methods 163: 360-367.
26. Huisman W, Martina BE, Rimmelzwaan GF, Gruters RA, Osterhaus AD, (2008) Vaccine-induced enhancement of viral infections. Vaccine.
27. McMullen AR, May FJ, Li L, Guzman H, Bueno R Jr, et al. (2011) Evolution of new genotype of West Nile virus in North America. Emerg Infect Dis 17: 785-793.
28. May FJ, Davis CT, Tesh RB, Barrett AD, (2011) Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol 85: 2964-2974.
29. Araujo JM, Nogueira RM, Schatzmayr HG, Zanotto PM, Bello G, (2009) Phylogeography and evolutionary history of dengue virus type 3. Infect Genet Evol 9: 716-725.
30. Klungthong C, Zhang C, Mammen MP Jr, Ubol S, Holmes EC, (2004) The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand. Virology 329: 168-179.
31. Myat Thu H, Lowry K, Jiang L, Hlaing T, Holmes EC, et al. (2005) Lineage extinction and replacement in dengue type 1 virus populations are due to stochastic events rather than to natural selection. Virology 336: 163-172.
32. Zhang C, Mammen MP Jr, Chinnawirotpisan P, Klungthong C, Rodpradit P, et al. (2006) Structure and age of genetic diversity of dengue virus type 2 in Thailand. J Gen Virol 87: 873-883.
33. Kanakaratne N, Wahala WM, Messer WB, Tissera HA, Shahani A, et al. (2009) Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg Infect Dis 15: 192-199.
34. Rigau-Perez JG, Ayala-Lopez A, Garcia-Rivera EJ, Hudson SM, Vorndam V, et al. (2002) The reappearance of dengue-3 and a subsequent dengue-4 and dengue-1 epidemic in Puerto Rico in 1998. Am J Trop Med Hyg 67: 355-362.
35. Nalca A, Fellows PF, Whitehouse CA, (2003) Vaccines and animal models for arboviral encephalitides. Antiviral Res 60: 153-174.
36. Zhang JS, Zhao QM, Guo XF, Zuo SQ, Cheng JX, et al. (2011) Isolation and genetic characteristics of human genotype 1 Japanese encephalitis virus, China, 2009. PLoS One 6: e16418.
37. Darwish MA, Hammon WM, (1966) Japanese B encephalitis virus vaccines from tissue culture. VII. Formalin inactivated Nakayama strain vaccine. Proc Soc Exp Biol Med 122: 813-816.
38. Okuno Y, Okamoto Y, Yamada A, Baba K, Yabuuchi H, (1987) Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus. Vaccine 5: 128-132.
39. Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, et al. (1988) Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319: 608-614.
40. Diamond MS, Pierson TC, Fremont DH, (2008) The structural immunology of antibody protection against West Nile virus. Immunol Rev 225: 212-225.
41. Throsby M, Geuijen C, Goudsmit J, Bakker AQ, Korimbocus J, et al. (2006) Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. J Virol 80: 6982-6992.
42. Crill WD, Hughes HR, Delorey MJ, Chang GJ, (2009) Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One 4: e4991.
43. Halstead SB, O'Rourke EJ, (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265: 739-741.
44. Monath TP, (2002) Japanese encephalitis vaccines: current vaccines and future prospects. Curr Top Microbiol Immunol 267: 105-138.
45. Ku CC, King CC, Lin CY, Hsu HC, Chen LY, et al. (1994) Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children. J Med Virol 44: 122-131.